Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.R.275
H.R.275: Medicare Prescription Drug Price Negotiation Act of 2019
About This Bill
- This bill was introduced in the 116th Congress
- This bill is primarily about health
- Introduced Jan. 8, 2019
- Latest Major Action Sept. 25, 2019
- See the six similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
37 (36 Democrats, 1 Republican)
Bill Version
- Introduced in House - Jan. 8, 2019
Bill Summary
Medicare Prescription Drug Price Negotiation Act of 2019 This bill requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits the CMS from doing so.
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
| Sept. 25, 2019 |
Subcommittee Hearings Held.
|
| Jan. 25, 2019 |
Referred to the Subcommittee on Health.
|
| Jan. 8, 2019 |
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
|
| Jan. 8, 2019 |
Referred to the Subcommittee on Health.
|
| Jan. 8, 2019 |
Introduced in the House by Peter Welch (D-Vt.) |